VS Diagnostics
www.vsdiagnostics.comQUANTITATIVE, EVIDENCE-BASED DIAGNOSTIC TESTING PROTOCOL EMPOWERING YOU TO: Objectively VALIDATE subjective pain scores. Yes! Based on 3-4 cardiac bio-markers, you can affirm that a patient is truly in Pain. QUANTIFY the effectiveness of any treatment algorithm---including weight loss, smoking cessation, maintenance medications, interventional pain therapies, physical therapy, medication management, etc. A patient’s cardiac bio-markers will improve as their overall health improves and pain decreases. MEASURE Physical and Mental Stress and the impact of pain EVALUATE compliance in treatment plans. ESTABLISH proper expectations for healing. IDENTIFY early on-set risk factors for cardiovascular disease, especially for t those patients that are experiencing other co-morbidities in addition to chronic pain. EXPOSE developing or advancing neuropathies, arterial stiffness, inflammation, etc ……critical in pre/post-op, or procedural protocols. MITIGATE risk and elevate MIPS/MACRA score ADD $35-50K/month in NET incremental revenue We look forward to learning more about your practice and sharing more of the VSD message. Message us to learn more and to get your confidential practice evaluation.
Read moreQUANTITATIVE, EVIDENCE-BASED DIAGNOSTIC TESTING PROTOCOL EMPOWERING YOU TO: Objectively VALIDATE subjective pain scores. Yes! Based on 3-4 cardiac bio-markers, you can affirm that a patient is truly in Pain. QUANTIFY the effectiveness of any treatment algorithm---including weight loss, smoking cessation, maintenance medications, interventional pain therapies, physical therapy, medication management, etc. A patient’s cardiac bio-markers will improve as their overall health improves and pain decreases. MEASURE Physical and Mental Stress and the impact of pain EVALUATE compliance in treatment plans. ESTABLISH proper expectations for healing. IDENTIFY early on-set risk factors for cardiovascular disease, especially for t those patients that are experiencing other co-morbidities in addition to chronic pain. EXPOSE developing or advancing neuropathies, arterial stiffness, inflammation, etc ……critical in pre/post-op, or procedural protocols. MITIGATE risk and elevate MIPS/MACRA score ADD $35-50K/month in NET incremental revenue We look forward to learning more about your practice and sharing more of the VSD message. Message us to learn more and to get your confidential practice evaluation.
Read moreCountry
State
Wyoming
City (Headquarters)
Cheyenne
Industry
Employees
11-50
Founded
2008
Social
Employees statistics
View all employeesPotential Decision Makers
Director , Us Sales / Business Development
Email ****** @****.comPhone (***) ****-****
Technologies
(22)